Výsledky vyhledávání - "Michèle Priester"

Étude en méthodologie mixte des attentes des personnes vivant avec le VIH en 2013 : la difficulté dans le regard de l’autre

Autor: Pierre Gantner, David Rey, Idalina Paupart, Béatrice Lindecker, Sophie Reinhart, Marialuisa Partisani, Erik De Mautort, Claudine Bernard-Henry, Christine Cheneau, Lucas Riegel, Michèle Priester, Sophie Revollon, Marie-Laure Batard

Publikováno v: Revue Francophone Internationale de Recherche Infirmière. 1:79-89

Resume Introduction Avec la simplification des traitements antiretroviraux, faut-il penser que l’education therapeutique du patient (ETP) chez les patients vivant avec le virus de l’immunodeficience humaine (VIH) n’est plus une necessite ? L’

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::28eb7940b323122ac3e4271eaca9d718
https://doi.org/10.1016/j.refiri.2015.04.001

Zobrazit plný text záznamu

Efficacy and safety of switching to raltegravir plus atazanavir dual therapy in pretreated HIV-1-infected patients over 144 weeks: a cohort study

Autor: Christine Koeppel, Patrice Muret, Marie-Laure Batard, David Rey, Michèle Priester, Samira Fafi-Kremer, Charlotte Sueur, Claudine Bernard-Henry, Pierre Gantner, Erik De Mautort, Christine Cheneau, Marialuisa Partisani

Publikováno v: Scandinavian Journal of Infectious Diseases. 46:838-845

To decrease drug burden among HIV-1-positive adults, we need a new gold standard for antiretroviral therapy maintenance strategies.This retrospective study aimed to assess efficacy in maintenance strategy of atazanavir (ATV) and raltegravir (RAL) dua

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad466edd2f0abb181f633f945d443f73
https://doi.org/10.3109/00365548.2014.947318

Zobrazit plný text záznamu

Plný text ve formátu HTML

Switching to emtricitabine, tenofovir and rilpivirine as single tablet regimen in virologically suppressed HIV-1-infected patients: a cohort study

Autor: Sophie Reinhart, Christine Cheneau, David Rey, Claudine Bernard-Henry, Marialuisa Partisani, M Baldeyrou, Patrice Muret, E. De Mautort, Samira Fafi-Kremer, M-L Batard, Michèle Priester, Pierre Gantner

Publikováno v: HIV Medicine. 16:132-136

Objectives Emtricitabine/tenofovir/rilpivirine as a single-tablet regimen (STR) is widely used without licence in treatment-experienced patients. The purpose of this retrospective observational study was to assess viral suppression of ART-experienced

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5f304aa2ddd07c41778a5bfc08444929
https://doi.org/10.1111/hiv.12183

Zobrazit plný text záznamu

Predictors of Standard Follow-Up Completion after Sexual Exposure to HIV: Five-Year Retrospective Analysis in a French HIV-Infection Care Center

Autor: Christine Cheneau, Constance De Miscault, Marie-Laure Batard, Pierre Gantner, David Rey, Michele Treger, Michèle Priester, Marialuisa Partisani, Claudine Bernard-Henry, Erik De Mautort

Publikováno v: PLoS ONE
PLoS ONE, Vol 10, Iss 12, p e0145440 (2015)

Objectives The care of exposed individuals to HIV remains a challenge regarding follow-up completion and HIV-testing of the partner. Identifying patients with risk of not fulfilling HIV-testing follow-up completion (FC), among patients demanding non-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16516b8855bbbd7f32b4f588d13e6859
http://europepmc.org/articles/PMC4687908

Zobrazit plný text záznamu

Séroprévalence de l'hépatite A chez des patients infectés par le VIH

Autor: Georgette Hess-Kempf, P. Meyer, Michèle Priester, David Rey, J. M. Lang, Christine Cheneau, E. Frick-Michot, M.-J. Wendling, Claudine Bernard-Henry, E. de Mautort, Marialuisa Partisani

Publikováno v: Médecine et Maladies Infectieuses. 35:402-406

Resume Objectifs. – Evaluer de maniere prospective la seroprevalence du virus de l'hepatite A dans la population de patients infectes par le VIH suivis en hopital de jour (CISIH Strasbourg). Patients et methodes. – Serologie de l'hepatite A (Ig t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::90893af388fe9a9fc5b8e5463e52f88a
https://doi.org/10.1016/j.medmal.2005.05.003

Zobrazit plný text záznamu

Bone mineral density changes after 2 years of ARV treatment, compared to naive HIV-1-infected patients not on HAART

Autor: Jean Sibilia, Christine Cheneau, Claudine Bernard-Henry, Rose-Marie Javier, Michèle Priester, David Rey, Michele Treger

Publikováno v: Infectious diseases (London, England). 47(2)

The prevalence of osteopenia and osteoporosis is increased in human immunodeficiency virus (HIV)-infected patients. The pathogenesis of this low bone mineral density (BMD) is multifactorial.We conducted a prospective study over a 2-year period of the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42bf9f91505de82073d367aab62c7377
https://pubmed.ncbi.nlm.nih.gov/25426996

Zobrazit plný text záznamu

Efavirenz as a Substitute for Protease Inhibitors in HIV-1–Infected Patients With Undetectable Plasma Viral Load on HAART: A Median Follow-Up of 64 Weeks

Autor: Claudine Bernard-Henry, Marie-Paule Schmitt, Erik De Mautort, Georgette Hess-Kempf, V. Krantz, J. M. Lang, Marialuisa Partisani, David Rey, Christine Cheneau, Michèle Priester

Publikováno v: Journal of Acquired Immune Deficiency Syndromes. 27:459-462

We investigated, in a prospective cohort follow-up study, whether substituting efavirenz (EFV) for protease inhibitors (PIs) could be safe in HIV-infected patients with optimal viral suppression achieved on PI-containing regimens. In patients with un

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51c44d8ee87bb47d35a0f23fe0ae9054
https://doi.org/10.1097/00042560-200108150-00006

Zobrazit plný text záznamu

Tolerance of a Short Course of Nevirapine, Associated With 2 Nucleoside Analogues, in Postexposure Prophylaxis of HIV

Autor: Georgette Hess-Kempf, Erik De Mautort, David Rey, Christine Cheneau, V. Krantz, Claudine Bernard-Henry, Marialuisa Partisani, Michèle Priester, J. M. Lang, Laetitia Decroix

Publikováno v: JAIDS Journal of Acquired Immune Deficiency Syndromes. 37:1454-1456

A combination of 2 nucleoside analogues and 1 protease inhibitor is usually recommended in postexposure prophylaxis. Because of the complex treatment schedule and frequent adverse effects, however, this regimen is often not completed. Therefore, sinc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6480c44394a7f384f35336e5eda3564b
https://doi.org/10.1097/01.qai.0000136732.00354.bd

Zobrazit plný text záznamu

Virologic response of zidovudine, lamivudine, and tenofovir disoproxil fumarate combination in antiretroviral-naive HIV-1-infected patients

Autor: Magali Krebs, David Rey, Erik De Mautort, J. M. Lang, Claudine Bernard-Henry, Michèle Priester, Marialuisa Partisani, Christine Cheneau, Georgette Hess

Publikováno v: Journal of acquired immune deficiency syndromes (1999). 43(5)

High rates of virologic failure have been reported in antiretroviral-naive patients receiving triple-nucleoside reverse transcriptase inhibitor (NRTI) combinations containing tenofovir disoproxil fumarate (TDF) with lamivudine (3TC) and didanosine or

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0221455a31509f7c05036afe2748425f
https://pubmed.ncbi.nlm.nih.gov/17057610

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání